Letter by Takahashi Regarding Article "Targeting Interleukin-1 in Heart Disease"

被引：1
|
作者：
Takahashi, Masafumi [1 ]
机构：
[1] Jichi Med Univ, Div Inflammat Res, Ctr Mol Med, Shimotsuke, Tochigi, Japan
来源：
CIRCULATION | 2014年 / 130卷 / 07期
关键词：
ISCHEMIA-REPERFUSION INJURY; NLRP3; INFLAMMASOME;
D O I：
10.1161/CIRCULATIONAHA.114.008658
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E62 / E62
页数：1
相关论文
共 50 条
  • [31] Interleukin-1 beta in coronary arteries of patients with ischemic heart disease
    Galea, J
    Armstrong, J
    Gadsdon, P
    Holden, H
    Francis, SE
    Holt, CM
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1996, 16 (08) : 1000 - 1006
  • [32] Involvement of Interleukin-1 Genotypes in the Association of Coronary Heart Disease With Periodontitis
    Geismar, Karen
    Enevold, Christian
    Sorensen, Lars Korsbaek
    Gyntelberg, Finn
    Bendtzen, Klaus
    Sigurd, Bjame
    Holmstrup, Palle
    JOURNAL OF PERIODONTOLOGY, 2008, 79 (12) : 2322 - 2330
  • [33] Elevated interleukin-1β in pericardial fluid of patients with ischemic heart disease
    Oyama, J
    Shimokawa, H
    Morita, S
    Yasui, H
    Takeshita, A
    CORONARY ARTERY DISEASE, 2001, 12 (07) : 567 - 571
  • [34] Targeting interleukin-1β and inflammation in lung cancer
    Jun Zhang
    Nirmal Veeramachaneni
    Biomarker Research, 10
  • [35] Reply to the letter by S. Niedzwecki regarding our article “Serum levels of interleukin-1 receptor antagonist (IL-1ra) in thyroid cancer patients”
    Sebastian Niedźwiecki
    Langenbeck's Archives of Surgery, 2009, 394 : 403 - 403
  • [36] Reply to the letter by S. Niedzwecki regarding our article "Serum levels of interleukin-1 receptor antagonist (IL-1ra) in thyroid cancer patients"
    Niedzwiecki, Sebastian
    LANGENBECKS ARCHIVES OF SURGERY, 2009, 394 (02) : 403 - 403
  • [37] Effects of Targeting the Interleukin-1 Receptor in a Murine Model of Sickle Cell Disease
    Venugopal, Jessica
    Wang, Jintao
    Guo, Chiao
    Eitzman, Daniel
    BLOOD, 2019, 134
  • [38] Rationale and efficacy of interleukin-1 targeting in pediatric Erdheim- Chester disease
    TA Tran
    JC Lecron
    D Pariente
    I Jéru
    A Delwail
    I Kone-Paut
    U Meinzer
    Pediatric Rheumatology, 9 (Suppl 1)
  • [39] Interleukin-1 and interleukin-1 receptor antagonist in inflammatory bowel disease - Discussion
    Mahida, Y
    Cominelli, F
    Jewell, DP
    Elson, CO
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1996, 10 : 54 - 54
  • [40] Response to Letter Regarding Article, "Nationwide Cohort Study of Risk of Ischemic Heart Disease in Patients With Celiac Disease"
    Ludvigsson, Jonas F.
    James, Stefan
    Askling, Johan
    Ingelsson, Erik
    CIRCULATION, 2011, 124 (16) : E423 - E423
12345